finance
Analysts Initiate Coverage on Three Biotech and Aerospace Stocks
Mizuho, Roth Capital, and an unnamed GE Aerospace analyst started coverage on Century Therapeutics, BioAge Labs, and GE Aerospace with positive ratings and price targets.
May 27, 7:43 AM·1m read1 source
thestreet.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
Mizuho analyst Salim Syed began coverage of Century Therapeutics Inc with an Outperform rating and an $8 price target. 17 on Tuesday. Roth Capital analyst Adam Walsh started coverage of BioAge Labs Inc with a Buy rating and a $36 price target.
A GE Aerospace analyst also initiated coverage on a bullish note, according to the report. The initiations form part of a broader set of analyst rating changes released on Wednesday.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
